Self-administration of subcutaneous depot medroxyprogesterone acetate: a pilot observational study of feasibility and acceptability

Contraception ◽  
2011 ◽  
Vol 84 (3) ◽  
pp. 320
Author(s):  
A. Sweet ◽  
S. Prabhakaran
2021 ◽  
Author(s):  
Adeniyi Kolade Aderoba ◽  
Petrus Steyn ◽  
James Njogu Kiarie

Self-administration of depot medroxyprogesterone acetate subcutaneous injectable contraception (DMPA-SC) is effective, safe and registered in many countries. It shows great potential to improve contraceptive access, continuation, and autonomy, including in low-income and middle-income countries. However, there are challenges to roll out this new efficacious intervention, and major implementation issues have been encountered for scale-up. This study aims to describe the implementation strategies to scale up self-administered DMPA-SC programs, the barriers, and facilitators to these programs, and the outcome of the implementation strategy used.


2021 ◽  
Vol 70 (20) ◽  
pp. 739-743
Author(s):  
Kathryn M. Curtis ◽  
Antoinette Nguyen ◽  
Jennifer A. Reeves ◽  
Elizabeth A. Clark ◽  
Suzanne G. Folger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document